[1]
“FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS”, Int. J. Pharm. Sci. Drug Res., vol. 8, no. 1, pp. 07–12, Jan. 2016, doi: 10.25004/IJPSDR.2016.080102.